LONDON, ONTARIO--(MARKET WIRE)--Sep 25, 2007 -- Stellar Pharmaceuticals Inc., (CDNX:SLX.V - News) (OTC BB:SLXCF.OB - News) (“Stellar” or the “Company”), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today reported that its CEO, Peter Riehl and CFO, Janice Clarke purchased a total of 20,000 shares of Stellar in the open market.
